Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Mirus™ for Sedation in Resuscitation

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients aged over 18 years~* In mechanical ventilation for more than 48 hours~* No intracranial hypertension~* In severe state of agitation measured by a sedation scale score greater than 2 RASS~* Agitation observed in two circumstances: receiving maximal doses of propofol (≥ 5 mg / kg / h) and / or midazolam (≥ 0.2 mg / kg / h), or weaning failure to stop the sedation agitation.~Exclusion Criteria:~* Presence of a severe head injury (Glasgow initial score between 3 and 8) requiring monitoring intracranial pressure and / or treatment of intracranial hypertension~* Sedation with dexmedetomidine~* Personal or family antecedent of anesthetic malignant hyperthermia~* Pregnant woman

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).